| Literature DB >> 31762353 |
Rune Vinther Madsen1,2, Denis Nam3, Jörg Schilcher4,5, Aleksey Dvorzhinskiy1, James P Sutherland1, F Mathias Bostrom1, Anna Fahlgren1,4.
Abstract
Background and purpose - Insufficient initial fixation or early micromotion of an implant is associated with a thin layer of fibrous tissue at the peri-implant interface. It is unknown if bone loss is induced by the fibrous tissue interface acting as an active biological membrane, or as a membrane that will produce supraphysiologic fluid flow conditions during gait, which activates the mechanosensitive osteocytes to mediate osteoclast differentiation. We investigated whether mechanically induced osteolysis is dependent on the fibrous tissue interface as a biologically active scaffold, or if it merely acts as a conduit for fluid flow, affecting the mechanosensitive osteocytes in the peri-prosthetic bone.Methods - Using a rat model of mechanically instability-induced aseptic loosening, we assessed whether the induction of osteoclast differentiation was dependent on the presence of a peri-implant fibrous interface. We analyzed the amount of osteoclast differentiation, osteocyte apoptosis, pro-resorptive cytokine expression and bone loss using immunohistochemistry, mRNA expression and micro-CT.Results - Osteoclast differentiation and bone loss were induced by mechanical instability but were not affected by the presence of the fibrous tissue membrane or associated with osteocyte apoptosis. There was no increased mRNA expression of any of the cytokines in the fibrous tissue membrane compared with the peri-implant bone.Interpretation - Our data show that the fibrous tissue membrane in the interface plays a minor role in inducing bone loss. This indicates that the peri-implant bone adjacent to loose bone implants might play an important role for osteoclast differentiation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31762353 PMCID: PMC7006729 DOI: 10.1080/17453674.2019.1695351
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.Overview of implants for instability-induced osteolysis and the studied rat tibia.
A. The central screw (S) and the pressure piston (P) that are placed in the titanium plate and implanted in the proximal tibia. Retrieved proximal tibia demonstrating the fibrous tissue that forms beneath the piston.
B. Histological section with the central (Ce) cortical bone underneath the pressure piston and the peripheral (Pe) cortical bone at the periphery. MicroCT images illustrating the central and peripheral bone volumes.
Figure 3.H&E stains showing the fibrous tissue membrane in the immediate loading group (upper row) with a fibrin clot with loose connective tissue after 5 days of loading, while the 5 days latency group (lower row) had dense richly vascularized fibrous tissue.
Figure 4.Number of osteoclasts and bone volume in the peripheral and central cortical bone. The results are subdivided based on the presence of the fibrous tissue. Blue-colored boxes indicate loaded specimens, while green-colored boxes refer to non-loaded specimens. indicates p < 0.05. Red lines are median, boxes IQR, and whiskers ±1.5 x IQR.
Percentage (SD) of osteocyte apoptosis and necrosis in the peri-prosthetic bone 5 days after the first loading session and in non-loaded controls
| Loaded Fibrous tissue | Non-loaded Fibrous tissue | |||
|---|---|---|---|---|
| Factor/location | present | absent | present | absent |
| Osteocyte apoptosis (%): | ||||
| Peripheral | 6.9 (4.7) | 4.0 (4.1) | 6.9 (7.0) | 2.7 (1.6) |
| Central | 3.0 (0.7) | 4.2 (2.7) | 4.3 (3.1) | 7.9 (4.5) |
| Osteocyte necrosis (%): | ||||
| Peripheral | 9.8 (4.8) | 6.5 (2.8) | 5.5 (3.3) | 5.7 (2.2) |
| Central | 14.7 (6.0) | 12.6 (8.1) | 17.8 (6.7) | 14.2 (4.1) |
Effect of loading: p = 0.04
Effect of fibrous tissue: p < 0.02
Effect of loading and fibrous tissue: p = 0.07.
Median of mRNA expression in the fibrous tissue and peri-prosthetic bone 24 hours after the first loading session
| Central bone Loaded | Peripheral bone Loaded | Fibrous tissue Loaded | ||||
|---|---|---|---|---|---|---|
| yes | no | yes | no | yes | no | |
| Gene | (n = 7) | (n = 5) | (n = 6) | (n = 6) | (n = 7) | (n = 2) |
| IL-6 | 0.56 | 0.11 | 0.96 | 0.13 | 0.68 | (0.09, 2.42) |
| HIF-1 | 4.25 | 1.22 | 2.95 | 1.67 | 2.38 | (0.72, 1.69) |
| SOST | 0.62 | 7.88 | 6.00 | 9.60 | 0.01 | (1.88, 0.08) |
| VEGF | 0.38 | 0.12 | 0.21 | 0.16 | 0.44 | (0.20, 0.11) |
| RANKL | 5.12 | 1.84 | 5.90 | 2.02 | 0.34 | (0.29, 2.35) |
| OPG | 1.11 | 0.33 | 0.52 | 0.54 | 0.08 | (0.06, 0.14) |
p < 0.05,
p < 0.07 when loaded samples were compared with non-loaded controls